RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...
In a recent article in Molecular Therapy, Sanofi presented preclinical data for an in vivo CAR-T platform that reengineers T cells directly within the body, bypassing the weeks-long ex vivo ...
New England Biolabs (NEB®) today announced the release of the EnClose Cell-free dbDNA Synthesis Kit, developed in ...
Researchers developed DoriVac, a DNA origami-based vaccine platform that precisely arranges antigens and adjuvants to enhance immune responses. In preclinical studies, it generated strong, broad ...
A data engineer from Sydney used AI to design what may be the world's first personalized mRNA cancer vaccine for a dog.
Paul Conyngham used a "chatbot to brainstorm possible cures" for his dog, Rosie, who was diagnosed with a deadly mast cell ...
Paul Conyngham claims he used AI tools like ChatGPT and AlphaFold to create custom mRNA vaccines that helped cure his dog’s cancer after traditional treatments failed to stop the tumour.
Australian tech entrepreneur Paul Conyngham claims that he used AI tools such as ChatGPT and AlphaFold to cure his dog's ...
A Sydney-based data scientist used AI to create a personalised cancer vaccine for his dog, leading to significant tumour ...
With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are ...
Pioneering clinical trial testing how personalised mRNA vaccines can enable the immune system to target recurring pancreatic cancer.
Silicon nanotube arrays deliver functional mRNA into human pluripotent stem cells for the first time, achieving up to 64% transfection without compromising stem cell identity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results